Every Form 4 that Celestica, Inc. (CLS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CLS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLS filings page.
CELESTICA INC Chief Executive Officer Robert Mionis reported multiple indirect sales of common shares on August 13, 2026. A total of 23,496 common shares were sold by an entity identified as “Mionis 2026 GRAT Number Two” at weighted average prices ranging from $360.00 to $365.39 per share, in open-market or private transactions effected pursuant to a Rule 10b5-1 plan adopted on March 11, 2026. Following these transactions, Mionis is reported as holding 453,697 common shares directly and 210,445 common shares indirectly through “Mionis 2026 GRAT Number One.”
MIONIS ROBERT reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC Chief Executive Officer Robert Mionis received an equity award of restricted share units. On August 11, 2026, he was granted 1,271 restricted share units (RSUs), each representing a contingent right to receive one common share or an equivalent value in cash. These RSUs vest on April 1, 2029, and following the grant he holds 1,271 RSUs directly.
Reeder David reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director David Reeder reported an equity compensation grant of 133 Director Restricted Share Units (D-RSUs) on August 11, 2026. Each D-RSU represents a contingent right to receive one common share or an equivalent cash value upon settlement, and the granted D-RSUs vest on May 20, 2027. Following this award, Reeder holds 700 D-RSUs directly.
Colpitts Christopher W. reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Christopher W. Colpitts received an equity-based compensation award in the form of 190 Director Restricted Share Units (D-RSUs) on August 11, 2026. Each D-RSU represents a contingent right to receive one common share or equivalent cash value, subject to any deferral election. These 190 D-RSUs vest on May 20, 2027, bringing Colpitts’ directly held D-RSU balance to 1,000 units after the grant.
Maletira Amar reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC reported that director Amar Maletira received a grant of 142 Director Restricted Share Units (D-RSUs) on August 11, 2026. Each D-RSU represents a contingent right to receive one common share or an equivalent cash value upon settlement, subject to any deferral election. These D-RSUs vest on May 20, 2027, bringing Maletira’s directly held D-RSU balance to 781 units following this grant.
KOELLNER LAURETTE T reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc director Laurette T. Koellner received an equity award of 317 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU is a contingent right to receive one common share upon settlement, subject to any deferral election, or, at Celestica’s election, an equivalent value in cash. These 317 D‑RSUs vest on May 20, 2027, bringing Koellner’s directly held D‑RSU balance to 1,127 units following the grant.
Kale Jill reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director Jill Kale received an equity-based compensation grant of 190 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU represents a contingent right to receive one common share or, at the company’s election, an equivalent cash amount. Following this award, Kale holds 1,000 D‑RSUs, which vest on May 20, 2027, subject to her deferral election.
Colpron Francoise reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director Francoise Colpron received a grant of 203 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU represents a contingent right to receive one common share upon settlement, or at the issuer’s election an equivalent value in cash. These D‑RSUs vest on May 20, 2027. Following this award, Colpron holds a total of 1,072 D‑RSUs directly.
CASCELLA ROBERT reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Robert Cascella reported an equity compensation grant of 142 Director Restricted Share Units (D‑RSUs) on August 11, 2026. Each D‑RSU represents a contingent right to receive one common share or equivalent cash value upon settlement. These D‑RSUs vest on May 20, 2027, bringing Cascella’s directly held D‑RSUs to 761 units following the award.
Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director Kulvinder Ahuja received an equity grant. On August 11, 2026, Ahuja was granted 133 Director Restricted Share Units (D‑RSUs), each representing a contingent right to receive one common share or an equivalent cash value at the issuer’s election. These D‑RSUs vest on May 20, 2027, and Ahuja now holds 700 D‑RSUs in total on a direct basis.
CELESTICA INC Chief Executive Officer Robert Mionis reported indirect sales of 51,061 Common Shares on August 5, 2026 through Mionis 2026 GRAT Number Two, at weighted average prices between $361.89 and $378.50 per share under a Rule 10b5-1 plan adopted March 11, 2026. Following these trades, he reports holdings of 453,697 Common Shares directly and 210,445 indirectly via Mionis 2026 GRAT Number One.
Celestica Inc. Chief Executive Officer Robert Mionis reported indirect sales of 98,453 common shares by Mionis 2026 GRAT entities on August 4, 2026. The non-derivative sales were executed in multiple open-market transactions at weighted-average prices, with individual trade prices within disclosed ranges from $360.00 to $374.43 per share, pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026.
After these transactions, reported holdings comprised 453,697 common shares held directly and 210,445 shares held indirectly through Mionis 2026 GRAT Number One.
Celestica Inc chief financial officer Mandeep Chawla sold 16,117 common shares on August 4, 2026 in 15 open market or private transactions at weighted average prices between $360.18 and $374.16 per share, under a Rule 10b5-1 trading plan adopted on March 13, 2026. Prices reported are weighted averages for trades executed within specified intraday ranges.
Celestica Inc reported that Chief Executive Officer Robert Mionis, acting indirectly through Mionis 2026 GRAT Number Three, sold 9,543 common shares on July 31, 2026 in a series of open-market transactions at weighted average prices between $360.47 and $374.49 per share, executed under a Rule 10b5-1 trading plan adopted on March 11, 2026. Following these trades, reported holdings included 453,697 common shares held directly, plus 210,445 shares via Mionis 2026 GRAT Number One and 145,565 shares via Mionis 2026 GRAT Number Two.
Celestica Inc Chief Financial Officer Mandeep Chawla reported selling 883 Common Shares of Celestica on July 31, 2026, in nine non-derivative transactions reported as sales in open market or private transactions. Per‑share prices ranged from $360.0000 to $374.0300. All sales were effected under a Rule 10b5-1 trading plan adopted on March 13, 2026, with several trades reported using weighted average prices over specified intra-day ranges.
Celestica Inc. director Robert Cascella reported routine equity compensation activity involving restricted share units (RSUs) and related tax withholding. On June 30, 2026, 84 RSUs converted into 84 common shares at a conversion price of $0.00 per share.
To cover tax obligations from this vesting, 5 common shares were withheld at a value of $343.25 per share, a tax-withholding disposition rather than an open-market sale. After these transactions, Cascella directly held 226 common shares and 169 RSUs, reflecting ongoing equity-based compensation rather than discretionary share trading.
Celestica Inc director Jill Kale reported routine equity compensation activity involving restricted share units (RSUs). On June 30, 2026, 155 Common Shares were acquired through the exercise of RSUs, while 9 Common Shares were withheld to cover tax obligations tied to the RSU vesting. Following these transactions, she directly held 416 Common Shares and 311 RSUs. Footnotes note that 466 RSUs were originally granted on June 30, 2025, with one-third vesting annually over three years, illustrating this as part of a scheduled vesting program rather than open-market trading.
Celestica Inc. reported a Form 4 showing open-market sales of common shares by a trust associated with Chief Executive Officer Robert Mionis. Mionis 2026 GRAT Number Three sold 18,176 common shares on June 17, 2026 at prices between $377.93 and $392.205 per share.
The filing notes these transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026. After these transactions, the report shows Mionis with 453,697 common shares held directly and additional indirect holdings of 210,445 and 145,565 common shares in Mionis 2026 GRAT Number One and Number Two, respectively.
Celestica Inc.'s Chief Executive Officer Robert Mionis reported a series of open-market sales of Common Shares on June 16, 2026 by an indirect holding vehicle, Mionis 2026 GRAT Number Three. The filing shows aggregate sales of 55,768 shares at weighted average prices generally between about $381 and $396 per share, executed in multiple trades. These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan. After these sales, the filing also reports continuing holdings of 453,697 Common Shares directly and additional indirect holdings of 210,445 and 145,565 Common Shares through two other 2026 GRAT entities.
Celestica Inc. Chief Executive Officer Robert Mionis reported open-market sales of 66,056 common shares on June 15, 2026. The transactions, carried out by Mionis 2026 GRAT Number Three, were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026.
The shares were sold in multiple trades at prices reported around $394–$414 per share, with each line showing a specific weighted-average price. After these sales, Mionis 2026 GRAT Number Three held 134,328 common shares, while separate filings show indirect holdings of 210,445 shares in Mionis 2026 GRAT Number One, 145,565 shares in Mionis 2026 GRAT Number Two, and a direct holding of 453,697 common shares.
Celestica Inc.’s Chief Financial Officer Mandeep Chawla reported open-market sales of 17,000 Common Shares on June 15, 2026. The Form 4 shows multiple trades at prices between $394.25 and $412.99 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026. After these transactions, Chawla directly owns 82,444 Common Shares of Celestica.
Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Kulvinder Ahuja reported equity-based compensation awards, not open-market trades. On May 20, 2026, Ahuja received 567 Director Restricted Share Units (D‑RSUs), each representing a right to one common share or equivalent cash and vesting on the first anniversary of the grant date.
On May 19, 2026, Ahuja was also granted 54 Director Share Units, which each represent a contingent right to receive one common share or equivalent cash when the holder ceases serving Celestica as a director, consultant, or other service provider. These awards increase Ahuja’s deferred and restricted share-based holdings but do not involve any purchase or sale of Celestica common shares in the market.
CASCELLA ROBERT reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Robert Cascella reported new equity-based compensation awards. On May 19, 2026, he was granted 58 Restricted Share Units (RSUs), each representing a contingent right to receive one common share or equivalent cash, with one-third vesting annually over three years.
On May 20, 2026, he received 619 Director Restricted Share Units (D‑RSUs), vesting on the first anniversary of the grant date. Each D‑RSU represents a contingent right to receive one common share upon settlement or an equivalent cash value. These are compensation grants, not open‑market share purchases or sales.
Colpron Francoise reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Francoise Colpron received new equity-based awards in the form of restricted share units. On May 19, 2026, Colpron was granted 115 Restricted Share Units (RSUs), each representing a contingent right to one common share or equivalent cash, vesting in three equal annual installments on each anniversary of the grant date.
On May 20, 2026, Colpron was granted 869 Director Restricted Share Units (D‑RSUs), which vest on the first anniversary of the grant date. Each D‑RSU similarly represents a contingent right to receive one common share upon settlement or, at Celestica’s election, an equivalent value in cash. These grants are compensation awards, not open‑market purchases or sales.
Kale Jill reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc director Jill Kale reported awards of new share-based compensation. On May 19, 2026, she received 108 restricted share units (RSUs), each representing a contingent right to one common share or equivalent cash, with one-third vesting annually over three years.
On May 20, 2026, she was granted 810 director restricted share units (D‑RSUs), which vest on the first anniversary of the grant date. These awards are compensation-related grants, not open‑market purchases or sales of Celestica common shares.
Reeder David reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director David Reeder received equity-based compensation in the form of share units. On May 20, 2026, he was granted 567 Director Restricted Share Units (D-RSUs), each representing a contingent right to receive one common share or cash, vesting on the first anniversary of the grant date.
On May 19, 2026, he was also granted 31 Director Share Units, each representing a contingent right to receive one common share or equivalent cash value when he ceases serving as a director, consultant or other service provider. After these awards, the filing shows holdings of 567 D-RSUs and 31 Director Share Units directly.
Colpitts Christopher W. reported acquisition or exercise transactions in this Form 4 filing.
CELESTICA INC director Christopher W. Colpitts received equity-based compensation in the form of director share units. On May 20, 2026, he was granted 810 Director Restricted Share Units (D‑RSUs), each representing a contingent right to one common share or cash, vesting on the first anniversary of the grant date.
On May 19, 2026, he was also granted 108 Director Share Units, each representing a contingent right to receive one common share or an equivalent cash amount when he ceases serving as a director, consultant or other service provider. These are compensation-related awards, not open-market purchases or sales.
Maletira Amar reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Amar Maletira reported equity-based compensation awards, not open-market trades. He received 639 Director Restricted Share Units (D‑RSUs) on May 20, 2026 and 121 Director Share Units on May 19, 2026, both at a price of $0.00 per unit.
Each unit represents a contingent right to receive one Celestica common share or an equivalent cash amount at the company’s discretion. The 639 D‑RSUs vest on the first anniversary of the grant date. Following these grants, Maletira holds 639 D‑RSUs and 1,413 Director Share Units, reflecting ongoing board compensation rather than cash purchases or sales in the market.
KOELLNER LAURETTE T reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Laurette T. Koellner reported awards of share-based compensation units. She received 810 Director Restricted Share Units on May 20, 2026, each representing a contingent right to one common share or equivalent cash and vesting on the first anniversary of the grant date. On May 19, 2026, she was also granted 108 Director Share Units, each tied to one common share or equivalent cash when she ceases serving as a director, consultant or other service provider. These are non-cash, compensation-related grants rather than open-market share purchases or sales.
Celestica Inc director Michael Max Wilson reported multiple equity transactions involving company stock and awards. On May 19, 2026, he sold 4,168 common shares at an average of $333.31 per share, with a footnote stating the sale was to satisfy tax withholding obligations from restricted share unit (RSU) vesting. After the sale, he directly held 24,718 common shares.
On the same date, he acquired 8,676 common shares through the exercise or conversion of RSUs and received a grant of 157 director share units, each representing a contingent right to one common share or cash. Several RSU grants from 2023 and 2024 fully vested upon his retirement on May 19, 2026.
Colpitts Christopher W. reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc director Christopher W. Colpitts received a grant of 276 director share units on March 31, 2026 at no cost. Each director share unit represents a contingent right to receive one common share or an equivalent cash amount when he ceases serving the company. Following this award, he directly holds 720 director share units tied to Celestica common shares.
Maletira Amar reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Amar Maletira received 300 Director Share Units as equity-based compensation. These units were granted at no cost and each represents a contingent right to receive one common share or an equivalent cash amount when he ceases serving Celestica as a director or other service provider.
Following this award, Maletira holds 1,292 Director Share Units linked to Celestica’s common shares, reflecting a routine, non-cash compensation grant rather than an open-market stock purchase or sale.
KOELLNER LAURETTE T reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc reported that director Laurette T. Koellner received a grant of 276 Director Share Units. These units were awarded at a price of $0.00 per unit as a form of equity compensation. Following this grant, Koellner holds a total of 446 Director Share Units. Each unit represents a contingent right to receive one common share of Celestica or an equivalent cash amount, at the company’s discretion, when she ceases serving as a director, consultant, or other service provider.
Celestica Inc. director Jill Kale reported routine equity compensation activity. On March 31, 2026, she exercised 287 Restricted Share Units (RSUs) into 287 Common Shares at $0.00 per share and had 17 Common Shares withheld at $257.27 per share to cover tax obligations.
She also received a new grant of 276 RSUs, each representing a contingent right to one Common Share or cash. Following these transactions, she directly holds 270 Common Shares and continues to hold RSUs granted on March 31, 2025 and March 31, 2026 that vest over three years.
Colpron Francoise reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Francoise Colpron received an equity award of 296 restricted share units on March 31, 2026. These RSUs were granted as compensation and give a contingent right to receive one common share or an equivalent cash amount for each unit.
According to the terms, one third of the 296 RSUs vests each year over three years on the anniversary of the grant date, so the award becomes fully vested over time rather than immediately.
Celestica Inc. director Robert Cascella reported routine equity compensation activity tied to restricted share units (RSUs). On March 31, 2026, he exercised 156 RSUs into the same number of common shares and received a new grant of 150 RSUs that vest in three annual installments starting on the grant anniversary. To cover tax obligations from the RSU vesting, 9 common shares were withheld at $257.27 per share, leaving him with 147 common shares directly held. After the transactions, he continues to hold 312 RSUs from a prior 468-unit grant in addition to the new 150-unit RSU award.
Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Kulvinder Ahuja received a grant of 138 Director Share Units. These units are a form of deferred compensation tied to the company’s common shares. After this award, Ahuja holds 633 Director Share Units in total.
Each Director Share Unit represents a right to receive one common share or an equivalent cash amount, at Celestica’s discretion, when the holder stops serving as a director, consultant or other service provider.
Celestica Inc. director Michael Max Wilson exercised equity awards and settled related taxes in shares. On March 31, 2026, he exercised restricted share units into 3,199 Common Shares and received an additional 398 Director Share Units as a grant.
To cover tax obligations from the RSU vesting, 1,536 Common Shares were withheld at a price of $257.09 per share, converted from Canadian dollars. After these transactions, he directly held 20,210 Common Shares, reflecting a modest net increase from compensation-related awards rather than open-market trading.
Celestica Inc. president Todd C. Cooper reported a charitable gift of company stock. On February 6, 2026, he transferred 15,600 common shares of Celestica to a donor-advised fund, which will use the shares for charitable purposes.
After this gift, Cooper directly beneficially owned 93,370 common shares of Celestica. The transaction was reported as a gift (code G) at a price of $0 per share, reflecting that no cash changed hands in connection with the transfer.
Celestica Inc. Chief Executive Officer Robert Mionis reported equity compensation activity involving restricted share units (RSUs) and common shares. On February 4, 2026, 12,133 RSUs were converted into 12,133 common shares at an exercise price of $0, increasing his directly held common shares.
To cover tax withholding arising from this RSU vesting, 4,775 common shares were withheld at a price of $297.45. After these transactions, Mionis directly owned 1,010,091 common shares and 24,267 RSUs. Each RSU represents a contingent right to receive one common share or an equivalent cash amount, and the RSUs referenced stem from a 36,400-unit grant made on February 4, 2025 that vests in stages over a three-year period.
Celestica Inc. president Todd C. Cooper reported multiple equity transactions on February 4, 2026. He exercised 1,986 restricted share units (RSUs) into common shares at $0, reflecting stock-based compensation vesting. To cover tax withholding from the RSU vesting, 921 common shares were withheld at a price of $283.51 per share.
On the same date, Cooper also sold 1,065 common shares at $283.51 per share in an open-market sale. After these transactions, he directly owned 108,970 common shares of Celestica Inc. and 3,971 RSUs, which each represent the right to receive one common share or equivalent cash value.
Celestica Inc.'s Chief Financial Officer, Mandeep Chawla, reported routine equity compensation activity. On February 4, 2026, 2,537 restricted share units were converted into the same number of common shares at an exercise price of $0, reflecting normal vesting.
On the same date, 1,359 common shares were withheld at a price of $297.45 to cover tax obligations from the RSU vesting, as explained in the footnotes. Following these transactions, Chawla directly owned 99,444 common shares and 5,074 restricted share units, illustrating ongoing alignment with shareholders through equity-based compensation.
Celestica Inc. Chief Operations Officer Yann L. Etienvre reported several equity transactions dated February 4, 2026. He exercised 2,217 restricted share units into common shares at an exercise price of $0. To cover tax withholding on the RSU vesting, 1,072 common shares were withheld.
After withholding, 1,145 common shares were sold at $283.51 per share, leaving him with 0 directly held common shares following the sale. He continued to beneficially own 4,435 restricted share units, each representing a contingent right to receive one common share or an equivalent cash amount.
Celestica Inc. executive Leila Wong reported equity compensation activity involving restricted share units and common shares. On February 4, 2026, 1,103 common shares were acquired at an exercise price of $0 following the vesting of restricted share units, bringing her directly held common shares to 14,995.
On the same date, 591 common shares were withheld at a price of $297.45 to cover tax obligations related to the RSU vesting, leaving 14,404 common shares directly owned afterward. In the derivative table, 1,103 restricted share units were converted into common shares at an exercise price of $0, and 2,207 restricted share units remained directly held.
Celestica Inc.'s Chief Legal Officer, Parker Douglas Michael, reported multiple transactions on February 4, 2026 related to the vesting of restricted share units (RSUs) and associated common share activity.
RSUs covering 1,159 and 883 common shares were exercised at an exercise price of $0 per share, reflecting the conversion of RSUs into common shares. To cover tax withholding on these vestings, 621 and 473 common shares were withheld, with reported prices of $286.8 and $283.51 per share, respectively, with the prices converted from Canadian dollars using the Bank of Canada rate on the transaction date.
The filing also shows open-market sales of 538 common shares at $286.8 per share and 410 common shares at $283.51 per share. Each RSU represents a contingent right to receive one common share or an equivalent value in cash, and prior RSU grants from February 4, 2025 are scheduled to vest over two- and three-year periods as described.
Celestica Inc. executive insider activity: Chief Strategy Officer Tzevelekis Theodoros reported multiple equity award events on February 5, 2026. Restricted share units (RSUs) covering 890 common shares and a separate grant covering 3,336 common shares were exercised into common shares at an exercise price of $0 per share.
To cover related tax obligations from RSU vesting, 395 common shares and 1,136 common shares were withheld at a price of $275.86 per share, as noted in the footnotes. Following these transactions, the filing shows direct beneficial ownership entries of 495 and 2,695 common shares, and 1,779 RSUs remaining from one award.
Celestica Inc. president Jason Phillips reported multiple equity transactions in early February 2026. On February 4, 2,537 restricted share units (RSUs) were converted into common shares at an exercise price of $0, and 1,116 common shares were withheld at $297.45 to cover taxes.
After these events, he sold 20,000 common shares on February 5 at $300.01 per share and 100,000 common shares on February 6 at $308.92 per share. Following the sales, he directly held 12,584 common shares and 5,074 RSUs. A footnote also notes 18,505 common shares previously omitted from earlier filings, now reflected through a Form 3 amendment.
Celestica Inc. reported that Chief Strategy Officer Tzevelekis Theodoros received a grant of 1,263 restricted share units (RSUs) on February 3, 2026. Each RSU represents a right to receive one common share or an equivalent cash value.
The 1,263 RSUs vest ratably over three years: on each of the first and second anniversaries of the grant date and on December 1 following the second anniversary. All 1,263 derivative securities are held as direct beneficial ownership after this grant.
Celestica Inc.’s Chief Legal Officer, Parker Douglas Michael, reported multiple equity award activities. On February 2, 2026, 3,449 and 2,415 restricted share units (RSUs) were exercised into common shares at $286.98 per share value reference, with 1,847 and 1,293 shares withheld to cover taxes and 1,602 and 1,122 common shares sold at the same price, leaving no common shares from those lots. On February 3, 2026, he received a new grant of 1,544 RSUs, each representing one common share or cash equivalent, vesting ratably over three years.
Celestica Inc.'s Chief Human Resources Officer, Leila Wong, reported several equity-compensation transactions. On February 2, 2026, 61,224 performance share units were exercised into an equal number of common shares at $0 exercise price, after PSUs were certified at 200% of target. Shares were then withheld for taxes and 28,450 common shares were sold at $286.98, with additional withholding of 1,730 shares and a sale of 1,500 shares at $287.45. Wong also exercised 3,230 restricted share units into common shares and received a new grant of 2,315 RSUs on February 3, 2026. Following these transactions, she directly held 13,892 common shares, plus 3,230 and 2,315 RSUs.